Buy These 3 Biotech Stocks Ripe for a Takeover (The Market Cap)

Exclusive Biotech Presentation: Wednesday 6pm (limited seats remain)

Ensure you continue to get this valuable content by whitelisting us (find out how here).

Monday, September 14, 2015 Edit Subscriber Profile  |  Unsubscribe  |  Privacy Policy

Buy These 3 Biotech Stocks Ripe for a Takeover Don't miss Bret Jensen's exclusive online presentation that will show you exactly how he consistently finds biotech winners no matter what the market is doing. Get 6 easy steps to find rising biotech stocks before they get acquired. World premiere is this Wednesday (Sept 16), but only a limited number of seats remain. Registration is FREE. Claim your seat - sign up now free.

FEATURE

Buy These 2 Small Biotechs with Huge Upside The small cap biotech space is inherently more volatile than other parts of the market. While this has created several bargains recently, Biotech Gems Analyst Bret Jensen profiles the only two stocks he is personally buying despite the current challenges in the market. The companies could have a huge near-term upside. Click to read more

EDITOR'S PICKS If History Repeats, This Sector Will Gain 40% in the Next 12 Months Free Registration: Consistently Find Biotech Stocks Before They Get Acquired & 3 Stocks Ripe for a Takeover Now [ad] OUR TOP INVESTING IDEAS   3 Must-Own Large Cap Biotechs for Stability and Growth If you have been sitting on the sidelines watching the biotech sector crush the S&P 500 over the last six years, now is your chance to get in the game. Investors can find great values to buy for growth and stability thanks to the recent market selloff. Click to read more You're Biologically Hardwired to Fail at Investing That's the truth. Human biology acts counter to your success at investing. But is investing hopeless? Not even close. Tim Plaehn explains how you can beat your biology and succeed in the markets day in and day out by using strategy and logic. Click to read more

© Copyright 1998-2015, Investors Alley Corp. All rights reserved. See Privacy Policy and Terms of Use | Contact Us

 

If you enjoyed reading this email, click here to forward it to a friend or colleague.

You are receiving this message because you registered ignoble.experiment@arconati.us through INO.com Invite Sell - Apr 2014.
Click here to send us comments or questions regarding this mailing. Unsubscribe/update profile using link below.

This message from Investors Alley Corp. is being sent in full accordance with the CAN-SPAM Act.
We respect your privacy and, therefore, this email was sent directly from Investors Alley.  Please review our Privacy Statement and Terms of Use. 
If you no longer wish to receive emails from Investors Alley, please opt-out using the link below.

The opinions in this email and corresponding web sites are neither an offer nor a recommendation to buy or sell any security. Investors Alley Corp. and its affiliates may hold a position in any of the companies mentioned.  Investors Alley Corp. is not a registered investment firm nor a broker/dealer.  We urge you to always conduct your own research and due diligence and obtain professional advice before making any investment decision.

All information contained herein is copyright 2015, Investors Alley Corp.
Investors Alley Corporation | 41 Madison Avenue | 31st Floor | New York, NY  10010

 

Update Your Profile Information | Modify Subscription Settings or Unsubscribe From Emails